Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-850 Phase 2 in Healthy Adults
NCT02713061Phase 2Withdrawn
- Sponsor
- Takeda
- Start
- Mar 2016
- Primary completion
- Apr 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of TAK-850 in influenza, sponsored by Takeda. Planned start Mar 2016; status: withdrawn.
02
Drugs
TAK-850
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02713061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02713061.